Advertisement
Screener

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) Research and Development Asset Acquired Other than Through Business Combination, Written-off

1.6 / 5 stars · 38/120 Roast Me

TEVA PHARMACEUTICAL INDUSTRIES LIMITED Research and Development Asset Acquired Other than Through Business Combination, Written-off

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Research and Development Asset Acquired Other than Through Business Combination, Written-off of $26.00 million for the 12-month period ending 2013-12-31, per its 20-F filed 2014-02-10.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff · last filed 2014-02-10

  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED research and development asset acquired other than through business combination, written-off for the quarter ending 2010-09-30 was $0.00.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED research and development asset acquired other than through business combination, written-off for the quarter ending 2010-06-30 was $5.00M.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED research and development asset acquired other than through business combination, written-off for the quarter ending 2010-03-31 was $4.00M.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED research and development asset acquired other than through business combination, written-off for the quarter ending 2009-09-30 was $0.00.
Period endResearch and Development Asset Acquired Other than Through Business Combination, Written-off 3 monthResearch and Development Asset Acquired Other than Through Business Combination, Written-off 6 monthResearch and Development Asset Acquired Other than Through Business Combination, Written-off 9 monthResearch and Development Asset Acquired Other than Through Business Combination, Written-off 12 month
2013-12-31$26.00M
20-F · filed 2014-02-10
2012-12-31$26.00M
20-F · filed 2013-02-12
2010-09-30$0.00
6-K · filed 2010-11-02
$5.00M
derived: sum of 2 quarters · filed 2010-11-02
$9.00M
6-K · filed 2010-11-02
2010-06-30$5.00M
6-K · filed 2010-07-27
$9.00M
6-K · filed 2010-07-27
2010-03-31$4.00M
6-K · filed 2010-05-04
2009-09-30$0.00
6-K · filed 2010-11-02
$0.00
6-K · filed 2010-11-02